Results 91 to 100 of about 27,419 (207)

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Clotting factor concentrate switching and inhibitor development in hemophilia A.

, 2012
The development of alloantibodies or inhibitors is the most serious complication a patient with severe hemophilia can experience from treatment with clotting factor concentrates.
M. Makris, PUCCETTI, Paolo, IORIO, Alfonso   +2 more
core   +1 more source

Guidelines for Submitting Adverse Event Reports for Publication

, 2009
Publication of case reports describing suspected adverse effects of drugs and medical products that include herbal and complementary medicines, vaccines and other biologicals and devices is important for postmarketing surveillance. Publication lends
Alina Fernandez, Stephen Freedman, Kui Huang, Nicholas Moore, Robert Wise, Judith Jones, Ralph Edwards, Frank Williams, Joanne Barnes, Thierry Trenque, Ulf Bergman, William Kelly, Felix Arellano, Eugène van Puijenbroek, David Goldsmith, Rosie Stather, Rachel McLeay, William Troutman   +17 more
core   +1 more source

Why Clinicians Don�t Report Adverse Drug Events: Qualitative Study (Preprint)

, 2017
BACKGROUND Adverse drug events are unintended and harmful events related to medications. Adverse drug events are important for patient care, quality improvement, drug safety research, and postmarketing ...
Chantelle Bailey, Serena S Small, Katherin Badke, Ellen Balka, Corinne M Hohl, David Peddie   +5 more
core   +1 more source

Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?

, 2019
Introduction: To adequately ascertain drug safety and efficacy, drug trials need to include participants from all groups likely to receive the medication following approval.
Michelle Moorhouse, Boffito, Marta, Abrams, Elaine J, Polly Clayden, Khoo, Saye, Serenata, Celicia, Moorhouse, Michelle, Moorehouse, Michelle, Helen Rees, Catriona Waitt, Saye Khoo, Celicia Serenata, Amandine Cournil, Marta Boffito, Shahin Lockman, Fairlie, Lee, Matthew Chersich, Abrams, Elaine, Elaine J. Abrams, Lee Fairlie, Clayden, Polly, Waitt, Catriona, Willem Francois Venter, Cherisch, Matthew, Rees, Helen, Chersich, Matthew, Cournil, Amandine, Lockman, Shahin, Venter, Willem Francois   +28 more
core   +1 more source

Caracterización de las reacciones adversas medicamentosas en ancianos. Matanzas. 2005-2009 Characterization of the adverse drug reactions in elder people. Matanzas. 2005-2009

Revista Médica Electrónica, 2011
La presente investigación caracterizó las notificaciones de sospechas de reacciones adversas medicamentosas en personas mayores de 60 años, recibidas en la Unidad Coordinadora Provincial de Farmacovigilancia, desde el 1 de enero de 2005 al 31 de ...
Leidy Santos Muñoz, Legdy Mari Martínez Padrón   +1 more
doaj  

Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety

Patient Preference and Adherence
Carlos De las Cuevas,1 Emilio J Sanz,2,3 Jose de Leon4,5 1Department of Internal Medicine, Dermatology, and Psychiatry and Instituto Universitario de Neurociencia (IUNE), Universidad de La Laguna, La Laguna, Canary Islands, Spain; 2Department of Physical
De las Cuevas C, Sanz EJ, de Leon J
doaj  

Falsificação de medicamentos no Brasil Falsificación de medicamentos en Brasil Counterfeiting of drugs in Brazil

Revista de Saúde Pública, 2012
OBJETIVO: Identificar os principais medicamentos falsificados apreendidos pela Polícia Federal brasileira e os estados em que houve a apreensão. MÉTODOS: Estudo retrospectivo descritivo dos laudos periciais elaborados por Peritos Criminais da Polícia ...
Joseane Ames, Daniele Zago Souza
doaj  

Safety and effectiveness of interferon β-1a intramuscular therapy: results of the postmarketing drug surveillance in Japan.

Rinshō shinkeigaku Clinical neurology, 2017
H. Makioka, Fuyuki Nakaya, Y. Ling, S. Torii, T. Saida, J. Kira   +5 more
semanticscholar   +1 more source